Investigating the Molecular Basis of the Aggregation Propensity of the Pathological D76N Mutant of Beta-2 Microglobulin: Role of the Denatured State.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
18 Jan 2019
Historique:
received: 27 11 2018
revised: 09 01 2019
accepted: 11 01 2019
entrez: 24 1 2019
pubmed: 24 1 2019
medline: 2 5 2019
Statut: epublish

Résumé

Beta-2 microglobulin (β2m) is a protein responsible for a pathologic condition, known as dialysis-related amyloidosis (DRA), caused by its aggregation and subsequent amyloid formation. A naturally occurring mutation of β2m, D76N, presents a higher amyloidogenic propensity compared to the wild type counterpart. Since the three-dimensional structure of the protein is essentially unaffected by the mutation, the increased aggregation propensity of D76N has been generally ascribed to its lower thermodynamic stability and increased dynamics. In this study we compare the equilibrium unfolding and the aggregation propensity of wild type β2m and D76N variant at different experimental conditions. Our data revealed a surprising effect of the D76N mutation in the residual structure of the denatured state, which appears less compact than that of the wild type protein. A careful investigation of the structural malleability of the denatured state of wild type β2m and D76N pinpoint a clear role of the denatured state in triggering the amyloidogenic propensity of the protein. The experimental results are discussed in the light of the previous work on β2m and its role in disease.

Identifiants

pubmed: 30669253
pii: ijms20020396
doi: 10.3390/ijms20020396
pmc: PMC6359115
pii:
doi:

Substances chimiques

Protein Aggregates 0
Recombinant Proteins 0
beta 2-Microglobulin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : 18701
Organisme : Fondazione Cariplo
ID : 2016-0489

Références

Biochemistry. 2000 Aug 1;39(30):8735-46
pubmed: 10913285
Biophys J. 2012 Apr 4;102(7):1676-84
pubmed: 22500768
J Biol Chem. 2011 Feb 4;286(5):3863-72
pubmed: 21118804
Nat Commun. 2018 Oct 30;9(1):4517
pubmed: 30375379
J Biol Chem. 2015 Apr 17;290(16):9951-8
pubmed: 25750126
J Clin Invest. 1985 Dec;76(6):2425-9
pubmed: 3908488
Nat Rev Mol Cell Biol. 2014 Jun;15(6):384-96
pubmed: 24854788
J Biol Chem. 2014 Feb 7;289(6):3318-27
pubmed: 24338476
Nature. 2005 Oct 13;437(7061):1053-6
pubmed: 16222301
N Engl J Med. 2012 Jun 14;366(24):2276-83
pubmed: 22693999
Sci Rep. 2016 May 06;6:25559
pubmed: 27150430
J Mol Biol. 2008 May 9;378(4):887-97
pubmed: 18395224
Crit Rev Biochem Mol Biol. 2005 Jul-Aug;40(4):181-9
pubmed: 16126485
Annu Rev Biochem. 2017 Jun 20;86:27-68
pubmed: 28498720
Nat Commun. 2019 Mar 7;10(1):1104
pubmed: 30846696
Curr Opin Struct Biol. 2007 Feb;17(1):3-14
pubmed: 17250999
Biochemistry. 1996 Feb 27;35(8):2738-49
pubmed: 8611580
J Am Chem Soc. 2010 Apr 28;132(16):5556-7
pubmed: 20356307
PLoS One. 2015 Dec 01;10(12):e0144061
pubmed: 26625273
Protein Sci. 1995 Oct;4(10):2138-48
pubmed: 8535251
Nat Commun. 2019 Mar 20;10(1):1269
pubmed: 30894521
Science. 2001 Jul 20;293(5529):487-9
pubmed: 11463915
ACS Chem Biol. 2017 Jun 16;12(6):1683-1690
pubmed: 28459531
Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):17772-6
pubmed: 22652570
J Am Chem Soc. 2011 Sep 14;133(36):14160-3
pubmed: 21650202
Annu Rev Biochem. 2006;75:333-66
pubmed: 16756495
J Mol Biol. 2003 Jul 25;330(5):943-54
pubmed: 12860118
Nat Struct Biol. 2001 Aug;8(8):659-60
pubmed: 11473247
Amyloid. 2007 Sep;14(3):179-83
pubmed: 17701465
Nat Commun. 2018 Apr 25;9(1):1658
pubmed: 29695721
Biochem Biophys Res Commun. 1985 Jun 28;129(3):701-6
pubmed: 3893430

Auteurs

Lorenzo Visconti (L)

Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimento di Scienze Biochimiche "A. Rossi Fanelli" and Istituto di Biologia e Patologia Molecolari del CNR, Sapienza Università di Roma, 00185 Rome, Italy. lorenzo.visconti@uniroma1.it.

Francesca Malagrinò (F)

Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimento di Scienze Biochimiche "A. Rossi Fanelli" and Istituto di Biologia e Patologia Molecolari del CNR, Sapienza Università di Roma, 00185 Rome, Italy. francesca.malagrino@uniroma1.it.

Luca Broggini (L)

Dipartimento di Bioscienze, Università degli Studi di Milano, 20133 Milano, Italy. luca.broggini@unimi.it.

Chiara Maria Giulia De Luca (CMG)

Fondazione IRCCS Istituto Neurologico Carlo Besta, Divisione di Neurologia 5-Neuropatologia, 20133 Milano, Italy. chiara.deluca@istituto-besta.it.

Fabio Moda (F)

Fondazione IRCCS Istituto Neurologico Carlo Besta, Divisione di Neurologia 5-Neuropatologia, 20133 Milano, Italy. Fabio.Moda@istituto-besta.it.

Stefano Gianni (S)

Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimento di Scienze Biochimiche "A. Rossi Fanelli" and Istituto di Biologia e Patologia Molecolari del CNR, Sapienza Università di Roma, 00185 Rome, Italy. stefano.gianni@uniroma1.it.

Stefano Ricagno (S)

Dipartimento di Bioscienze, Università degli Studi di Milano, 20133 Milano, Italy. Stefano.ricagno@unimi.it.

Angelo Toto (A)

Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimento di Scienze Biochimiche "A. Rossi Fanelli" and Istituto di Biologia e Patologia Molecolari del CNR, Sapienza Università di Roma, 00185 Rome, Italy. Angelo.Toto@uniroma1.it.

Articles similaires

T-Lymphocytes, Regulatory Lung Neoplasms Proto-Oncogene Proteins p21(ras) Animals Humans

Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis.

Spencer D Shelton, Sara House, Luiza Martins Nascentes Melo et al.
1.00
DNA, Mitochondrial Humans Melanoma Mutation Neoplasm Metastasis
Aspergillus Hydrogen-Ion Concentration Coculture Techniques Secondary Metabolism Streptomyces rimosus

Prevalence and implications of fragile X premutation screening in Thailand.

Areerat Hnoonual, Sunita Kaewfai, Chanin Limwongse et al.
1.00
Humans Fragile X Mental Retardation Protein Thailand Male Female

Classifications MeSH